Table VI.
Multivariate analysis of the prognostic factors in stage III NSCLC.
| Prognostic factor | Hazard ratio | 95% Confidence interval | p-value |
|---|---|---|---|
| Age (≤65 years/>65 years) | 0.809 | 0.381–1.716 | 0.5798 |
| Gender (male/female) | 0.921 | 0.603–1.408 | 0.7045 |
| Disease stage (IIIA/IIIB) | 0.914 | 0.607–1.378 | 0.6692 |
| Histology (AC/non-AC) | 1.350 | 0.846–2.156 | 0.2082 |
| LAT1 (positive/negative) | 1.529 | 1.053–2.219 | 0.0255 |
| CD98 (positive/negative) | 2.118 | 1.140–3.934 | 0.0175 |
| Ki-67 labeling index (low/high) | 1.531 | 0.839–2.794 | 0.1652 |
| N factor (N0–1/N2–3) | 0.664 | 0.410–1.136 | 0.1231 |
Hazard ratios, 95% confidence intervals and two-sided p-values were obtained from the Cox proportional hazards models. LAT1, L-type amino acid transporter 1; AC, adenocarcinoma.